Called enpatoran, the agent targets the Toll-like receptor (TLR) species 7 and 8. Some 50%-60% of patients with systemic lupus erythematosus (SLE) receiving it at different doses obtained so ...

Dapirolizumab Pegol Phase 3 Data in SLE Presented at the Annual European Congress of Rheumatology (EULAR) Show Improvement in Fatigue and Reduction in Disease Activity ...

About Enpatoran Enpatoran is a selective Toll-like receptor (TLR)7/8 inhibitor under investigation for the treatment of systemic lupus erythematosus (SLE) and cutaneous lupus erythematosus (CLE).

Explore Fate Therapeutics' pipeline, financials, and market position to assess if its 75% drop reflects true value or sector-wide trends. Click here to read.

NAPCO Security Technologies is proud to announce the availability of the new StarLink Black Max2 SLE-MAX-2L Intrusion Cellular Communicator, now available at security distributors nationwide at an ...

The Rundown: SLE Rodeo trots into town, Smooth Jazz Fest & more Weekend events happening from March 14th-16th The API failed to deliver the resource.

A majority of patients with systemic lupus erythematosus achieve prolonged remission when treated with hydroxychloroquine at a stable dose of 3-3.5 mg/kg/day.

The new data “shows robust benefit and lupus and DM,” William Blair analysts wrote, pointing to improvements in disease severity across all patients.

The FDA has granted Fast Track designation to ADI-001 for the treatment of refractory systemic lupus erythematosus with extrarenal involvement.

ADI-001 was granted Fast Track Designation by the FDA for the treatment of relapsed/refractory class III or class IV lupus nephritis (LN), and SLE with extrarenal involvement.

People with systemic lupus erythematosus (SLE) may experience problems with sleep. Learn what can cause sleep disturbances in lupus and how to improve sleep.

GM has deleted the SLE and SLT trims from the GMC Yukon lineup, replacing both with the new 2025 GMC Yukon Elevation. Will the same happen to the GMC Sierra?